National Institute Of Immunology
- All
- News
-
National Institute Of Immunology Gets Trademark For India's First Indigenous Tumor Antigen SPAG9
The SPAG9 antigen developed by the National Institute of Immunology (NII) has received the ASPAGNIITM trademark, the Department of Biotechnology (DBT) said on Friday.
-
NII's Potential COVID-19 Vaccine Shows Encouraging Results On Mice
An immunogenicity study conducted on mice for the coronavirus vaccine candidate being developed by the National Institute of Immunology has shown encouraging results, NII director Amulya Panda said on Friday.
-
AIDS vaccine: Scientists say breakthrough within reach
A 2009 clinical trial in Thailand was the first to show it was possible to prevent HIV infection in humans. Now scientists believe a licensed vaccine is within reach.
-
National Institute Of Immunology Gets Trademark For India's First Indigenous Tumor Antigen SPAG9
The SPAG9 antigen developed by the National Institute of Immunology (NII) has received the ASPAGNIITM trademark, the Department of Biotechnology (DBT) said on Friday.
-
NII's Potential COVID-19 Vaccine Shows Encouraging Results On Mice
An immunogenicity study conducted on mice for the coronavirus vaccine candidate being developed by the National Institute of Immunology has shown encouraging results, NII director Amulya Panda said on Friday.
-
AIDS vaccine: Scientists say breakthrough within reach
A 2009 clinical trial in Thailand was the first to show it was possible to prevent HIV infection in humans. Now scientists believe a licensed vaccine is within reach.
